What is the Impact Factor of Immunotherapy Advances?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Immunotherapy Advances is 4.40, ranking in quartile Q2 of Web of Science (ESCI).

Is Immunotherapy Advances indexed in Web of Science or Scopus?

Yes, Immunotherapy Advances is indexed in Web of Science (ESCI, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.504 (Q1) and an H-index of 20.

Who publishes Immunotherapy Advances and what is the Article Processing Charge (APC)?

Immunotherapy Advances is published by Oxford University Press. The estimated Article Processing Charge (APC) is approximately $3,603 USD, subject to institutional waivers and corresponding author affiliations.

WoS ESCI Q2Scopus Q1SCImago #2,433Gold OA

Immunotherapy Advances

Identifier (ISSN):2732-4303(Online)

•

Publisher:Oxford University Press

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

4.4↓ -0.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Immunotherapy Advances

WoS Q2

Annual Impact Factor Metric

Current (2026):4.4

Scopus SJR & RankScopus Q1

1.504

#2,433

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

20 papers with at least that number of citations each

WoS: ESCIQ2

Self-Citation Rate2.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

5articles/year

100% Gold OA•0% Original Research

Aims & Scope

Immunotherapy Advances is a peer-reviewed international scholarly journal in the field of Medicine, published by Oxford University Press in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 4.40, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.504 (Q1), an H-index of 20.

Topics Covered (Recognized by AI)

BiologyMedicineGeneticsInternal MedicineImmunologyImmune SystemChemistryBiochemistryOncology & Cancer ResearchPathologyCancer ResearchAntibodies & ImmunologyReceptors & PharmacologyEndocrinologyPathology & Diseases

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

IMMUNOLOGY

Rank63/183

IndexESCI

JCIESCI2026

IMMUNOLOGY

Rank105/183

IndexESCI

Category	Index	Rank	Quartile
IMMUNOLOGY	JCRESCI	63/183	Q2
IMMUNOLOGY	JCIESCI	105/183	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

7 year

2026Latest

IF4.4

Articles / Year5

Total Citations0

2025

IF4.9

Articles / Year20

Total Citations1

2024

IF4.1

Articles / Year42

Total Citations201

2023

IF0

Articles / Year32

Total Citations373

2022

IF—

Articles / Year23

Total Citations429

Year	Impact Factor	Articles / Year	Total Citations
2026	4.4	5	0
2025	4.9	20	1
2024	4.1	42	201
2023	0	32	373
2022	—	23	429
2021	—	27	624
2020	—	11	169

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,433Scopus Q1SCImago Profile

Scopus Coverage:2021-2026

•

Scopus Broad Areas:Immunology and Microbiology

Scopus Citation Rank (SJR)Q1

1.504

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.28

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,603 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations296

3-Year Documents62

Citable Documents59

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 2.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区IMMUNOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 5 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,603 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.